← Back to Clinical Trials
Recruiting NCT06467396
Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
Trial Parameters
Condition Acute Ischemic Stroke
Sponsor Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-04-09
Completion 2025-04
Interventions
Large Vessel Occlusion Biomarkers Test
Brief Summary
The goal of this observational study is to evaluate the accuracy of a panel of blood biomarkers and clinical variables in predicting the prognosis of stroke patients treated by mechanical thrombectomy, specifically to predict futile recanalization and mortality.
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years old. * Patient in whom a mechanical thrombectomy is performed. Exclusion Criteria: * Impossibility of getting a blood sample. * Impossibility of performing the test (Invalid results) * Refusal to provide the informed consent by the patient/relative.
Related Trials
NCT07174505
Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke
View Trial →
NCT05832762
Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery
View Trial →
NCT05145283
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral
View Trial →